Diacerein + Aceclofenac Tablet Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 50mg + 100mg
Reference Brands: Dycerin A
Category:
Analgesic
ACECLOFENAC+DIACEREIN belongs to a group of medicines called Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) used to reduce and relieve pain, redness and inflammation (swelling) in patients suffering from osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis.
Diacerein + Aceclofenac Tablet is available in Tablets
and strengths such as 50mg + 100mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Diacerein + Aceclofenac Tablet is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Diacerein + Aceclofenac Tablet can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Diacerein + Aceclofenac tablets are regulated in the EU and US, supported by dossiers demonstrating safety, efficacy, and manufacturing quality based on GMP standards. In the US, approval involves validation, clinical safety, and efficacy assessments, though this combination is mainly used in compounded formulations. In the EU, CE marking certifies conformity with MDR standards, with some formulations approved for osteoarthritis. These products undergo validation, stability testing, and audits, with comprehensive documentation including safety profiles, clinical data, and manufacturing practices. For licensing procedures, approved dossiers, and regulatory updates, visit Pharmatradz. Compliance concerns ensure access to high-quality combination therapies supporting joint health worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing